澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

AROVELLA THERAPEUTICS LTD

0.090

+0.0011.12%

成交量：77.12万

成交额：6.94万

市值：1.08亿

市盈率：-13.15

高：0.092

开：0.090

低：0.089

收：0.089

52周最高：0.195

52周最低：0.068

股本：12.01亿

流通股本：8.96亿

量比：0.80

换手率：0.09%

股息：- -

股息率：- -

每股收益(TTM):-0.007

每股收益(LYR):-0.007

净资产收益率：-52.05%

总资产收益率：-32.25%

市净率：5.71

市盈率(LYR):-13.15

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Arovella Therapeutics向美国FDA提交Ala-101首次人体一期试验新药研究申请

Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请获准授权

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ALA.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ALA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","market":"AU","secType":"STK","nameCN":"AROVELLA THERAPEUTICS LTD","latestPrice":0.09,"timestamp":1771564320000,"preClose":0.089,"halted":0,"volume":771235,"delay":0,"changeRate":0.011235955056179785,"nameEN":"AROVELLA THERAPEUTICS LTD","floatShares":895858885,"shares":1201183672,"eps":-0.006843,"marketStatus":"未开盘","change":0.001,"latestTime":"02-20 16:12:00 AEDT","open":0.09,"high":0.092,"low":0.089,"amount":69366,"amplitude":0.033708,"askPrice":0.09,"askSize":295041,"bidPrice":0.088,"bidSize":150000,"shortable":3,"etf":0,"ttmEps":-0.006843,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1771801200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.089,"openAndCloseTimeList":[[1771542000000,1771563600000]],"volumeRatio":0.7974071793831532,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ALA.AU\",,,,,undefined,":{"symbol":"ALA.AU","floatShares":895858885,"roa":"-32.25%","roe":"-52.05%","lyrEps":-0.006843,"volumeRatio":0.7974071793831532,"shares":1201183672,"dividePrice":0,"high":0.092,"amplitude":0.033708,"preClose":0.089,"low":0.089,"week52Low":0.068,"pbRate":"5.71","psRate":"33.68","week52High":0.195,"institutionHeld":0,"latestPrice":0.09,"committee":-0.325905,"eps":-0.006843,"divideRate":0,"volume":771235,"delay":0,"ttmEps":-0.006843,"open":0.09,"prevYearClose":0.093,"prevWeekClose":0.093,"prevMonthClose":0.086,"prevQuarterClose":0.093,"fiveDayClose":0.093,"twentyDayClose":0.09,"sixtyDayClose":0.083},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALA.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138242283","title":"Arovella Therapeutics向美国FDA提交Ala-101首次人体一期试验新药研究申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1138242283","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138242283?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 09:19","pubTimestamp":1767057555,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Ltd宣布已正式向美国食品药品监督管理局提交Ala-101的新药临床试验申请，该项申请旨在启动该药物的首次人体一期临床试验。这一重要进展标志着公司创新疗法开发迈入新的阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALA.AU","BK7096"],"gpt_icon":0},{"id":"1121490968","title":"Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请获准授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1121490968","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121490968?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 06:29","pubTimestamp":1756333754,"startTime":"0","endTime":"0","summary":"Arovella Therapeutics Ltd的CAR-iNKT细胞平台美国专利申请将获得授权批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ALA.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALA.AU\",params:#limit:6,delay:true,,,undefined,":[]}}